Skip to main content
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.315
-0.015 (-1.13%)
Mar 9, 2026, 2:23 PM EDT - Market open

Fate Therapeutics Revenue

In the year 2025, Fate Therapeutics had annual revenue of $6.65M, down -51.24%. Fate Therapeutics had revenue of $1.37M in the quarter ending December 31, 2025, a decrease of -26.40%.

Revenue (ttm)
$6.65M
Revenue Growth
-51.24%
P/S Ratio
22.92
Revenue / Employee
$41,280
Employees
161
Market Cap
152.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.65M-6.99M-51.24%
Dec 31, 202413.63M-49.90M-78.55%
Dec 31, 202363.53M-32.77M-34.03%
Dec 31, 202296.30M40.45M72.44%
Dec 31, 202155.85M24.41M77.66%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Karyopharm Therapeutics 146.07M
MacroGenics 127.63M
Zentalis Pharmaceuticals 26.87M
Innate Pharma 14.84M
Rani Therapeutics Holdings 1.20M
Artiva Biotherapeutics 251.00K
Revenue Rankings

FATE News

More News